← Back
Data updated: Mar 10, 2026
ENTASIS THERAP
Infectious Disease
ENTASIS THERAP is a pharmaceutical company focused on Infectious Disease. Key products include XACDURO (COPACKAGED).
2023
Since
2
Drugs
-
Trials
1
Approved (2yr)
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Infectious Disease 100%
0 drugs Phase 3: 1 Phase 2: 1 Phase 1: 4
Pipeline Strength Pro
Loading...
Active (2)
Discontinued (0)
Company Info
- First Approval
- 2023-05-23
- Latest
- 2025-12-12
- Applications
- 2